Lindsay A. Rosenwald M.D., Director at Checkpoint Therapeutics, Inc. (CKPT), bought 100,000 shares at $1.27 ($127K) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market purchase of $127k CKPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| FBIO | BUY | 2024-05-20 | $18K | — | Filing → |
| DERM | BUY | 2024-03-27 | $30K | — | Filing → |
| DERM | BUY | 2024-03-25 | $68K | — | Filing → |